Displaying 1–25 of 141 results for Packaging
Pfizer has recalled two lots of migraine drug Relpax after finding those lots “may not meet Pfizer’s in-house microbiological specification for the potential presence” of two kinds of bacteria.
Natco Pharma has received a Form 483 with six observations from the U.S. FDA for the drugmaker's active pharmaceutical ingredient facility located outside Hyderabad, India.
Fujifilm has acquired a large-scale biologics site near Copenhagen, Denmark.
pharma manufacturing news in review
Merck Sharp and Dohme will invest some $680 million in new manufacturing space and expanded packaging space to support its HPV vaccine Gardisil.
According to the Competition Commission in South Africa, the deal was not likely to reduce competition.
As GlaxoSmithKline readies a spin-off of its consumer healthcare business, the company is looking to shed certain parts of its portfolio.
New Jersey-based Heritage Pharmaceuticals is seeking damages from a Port of Virginia blunder that sent a container of its drugs toppling into the Elizabeth River.
McKesson Corp is back in the spotlight for opioid-related violations — this time involving rules under the 2013 Drug Supply Chain Security Act.
Boehringer Ingelheim will be cutting 327 jobs but also plans to create 32 new ones.
Since 2012, Pfizer's Hospira plant in Kansas has received eight FDA Form 483 citations.
With layoffs looming, Pfizer has reportedly offered eligible employees in the U.S. a severance package if they retire early.
Bayer AG announced it will cut 227 jobs connected to its Berkeley, California manufacturing operations, as it preps a new manufacturing plant in Germany.
Under the terms of the agreement, Dr. Reddy’s sold all the issued and outstanding membership interests in Dr. Reddy’s Laboratories Tennessee, LLC and certain related assets.
The FDA has rejected a request from Amicus Therapeutics to seek accelerated approval of an experimental drug for Pompe disease, asking for more data.
Editors highlight 18 products that have distinguished themselves as leaders in pharmaceutical equipment innovation
Pfizer and Antares Pharma have announced an agreement to develop a combination drug device opioid overdose “rescue pen.”
Amazon has announced that it will be buying the venture capital-backed startup, PillPack.
The Bausch+Ströbel filler can fill 200 vials per minute and will more than triple GRAM’s manufacturing capacity.
Bayer is voluntarily recalling Alka-Seltzer Plus packages that were sold in the U.S. at Walmart, CVS, Walgreens and Kroger after February 9, 2018, due to a labelling error.
New research from the University of Illinois at Chicago suggests that common flu treatment, Tamiflu, does not cause an increased risk of suicide in pediatric patients.
"The Manufacturing Process" is a comprehensive solid dose training course offering practical information on how tablets and capsules are made. Participants will be able identify machinery, why it is used, and what it does